THE ONCOLOGY INSTITUTE INC. - COMMON STOCK
2.8000
02-May-25 16:45:00
15 minutes delayed
Stocks
+0.0100
+0.36%
Today's range
2.6721 - 2.9200
ISIN
N/A
Source
NASDAQ
-
07 May 2024 16:05:00 By Nasdaq GlobeNewswire
-
The Oncology Institute Announces First Quarter 2024 Earnings Release Date and Conference Call
23 Apr 2024 08:00:00 By Nasdaq GlobeNewswire
-
Jordan McInerney Appointed as Chief Development Officer of The Oncology Institute
08 Apr 2024 08:00:00 By Nasdaq GlobeNewswire
-
04 Apr 2024 08:00:00 By Nasdaq GlobeNewswire
-
27 Mar 2024 16:05:00 By Nasdaq GlobeNewswire
-
MaxHealth & The Oncology Institute Expand Value-Based Care Partnership
14 Mar 2024 08:09:05 By Nasdaq GlobeNewswire
-
06 Mar 2024 08:00:00 By Nasdaq GlobeNewswire
-
The Oncology Institute to Participate at Upcoming Investor Conferences
27 Feb 2024 16:05:00 By Nasdaq GlobeNewswire
-
Carrum Health and The Oncology Institute Partner on Breast Cancer Treatment Model
20 Feb 2024 08:00:00 By Nasdaq GlobeNewswire
-
25 Jan 2024 08:00:00 By Nasdaq GlobeNewswire
-
04 Dec 2023 08:00:00 By Nasdaq GlobeNewswire
-
08 Nov 2023 16:05:01 By Nasdaq GlobeNewswire
-
The Oncology Institute Announces Third Quarter 2023 Earnings Release Date and Conference Call
18 Oct 2023 08:03:01 By Nasdaq GlobeNewswire
-
The Oncology Institute Names Jeremy Castle as Chief Operations Officer
11 Oct 2023 16:05:00 By Nasdaq GlobeNewswire
-
26 Sep 2023 16:05:00 By Nasdaq GlobeNewswire
-
The Oncology Institute Regains Compliance with Nasdaq Listing Requirements
18 Sep 2023 08:00:00 By Nasdaq GlobeNewswire
-
08 Aug 2023 16:40:50 By Nasdaq GlobeNewswire
-
The Oncology Institute Partners with House Rx to Accelerate Growth of Pharmacy Operations
31 Jul 2023 08:00:01 By Nasdaq GlobeNewswire
-
The Oncology Institute Announces Second Quarter 2023 Earnings Release Date and Conference Call
18 Jul 2023 08:00:02 By Nasdaq GlobeNewswire